© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Latest Conference Articles
ADA 2021: Renoprotection with Finerenone Consistent Regardless of SGLT2 Inhibitor Use
June 26th 2021
ADA 2021. A prespecified subanalysis of FIDELIO-DKD found primary and secondary renal and CV endpoints consistent whether or not SGLT2 inhibitors were on board at study baseline.
ADA 2021: Study Finds Hospitalization Rates for New-onset Pediatric T2D Doubled During Pandemic
June 25th 2021
Data released today at the American Diabetes Association 81st Scientific Sessions on a spike in new onset pediatric T2D at a single center during COVID-19 may signal much wider incidence.
ADA 2021 Symposia Focus on Health Disparities Exposed and Deepened by COVID-19 Pandemic
June 25th 2021
Leading international diabetes researchers and clinicians will use the ADA's 81st annual Scientific Sessions as an ideal classroom to examine pandemic impact on diverse populations with diabetes.
ADA Virtual Meeting Will Offer 5 Symposia on Latest COVID-19 Findings
June 24th 2021
The upcoming ADA virtual 81st Scientific Sessions will feature 5 sessions on the latest diabetes developments learned during the initial phases of the COVID-19 pandemic.
Clinical Trial Updates at the ADA Scientific Sessions 2021: A few primary care musts
June 21st 2021
The American Diabetes Association 2021 Scientific Sessions run from June 25 to 29. This short slide show highlights 6 clinical trial updates that are a "must see" for primary care clinicians.
ACC.21: High- and Low-Dose Aspirin Both Effective for Patients with Established Cardiovascular Disease
May 21st 2021
ACC.21: There was no difference found between high- and low-dose aspirin in terms of effectiveness and safety in patients with established CVD, according to new research.
ACC.21: Survival After MI Far Worse for Black Patients from Disadvantaged Neighborhoods
May 14th 2021
ACC.21: Black patients from disadvantaged neighborhoods were found almost 20% more likely to die within 5 years of MI than white patients from well-resourced ones in a new study.
ATS 2021: Tezepelumab Reduces Exacerbations in Oral Corticosteroid-dependent Patients with Severe Asthma
May 13th 2021
ATS 2021: In a subgroup of oral corticosteroid-dependent patients with severe asthma from the newly released NAVIGATOR study, tezepelumab reduced exacerbations and improved lung function.
ATS.2021: Study Finds Odds of Uncontrolled Asthma Increase with Higher Pandemic-related Stress
May 13th 2021
ATS.2021: Odds of uncontrolled asthma in response to pandemic-related stress increased in a significant dose-response manner among adult respondents to a new survey.
ACC.21: Prediabetes Significantly Increases Risk for MACE, According to New Findings
May 13th 2021
ACC.21: Findings from a study released in advance of the ACC annual meeting suggest that prediabetes confers nearly twice the risk of major cardiovascular events vs normoglycemia.